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Executive Summary:
Numerous studies have indicated an association between vitamin D deficiency and the immune
dysregulation and the pathogenesis of autoimmunity. An increased prevalence of vitamin D
deficiency has been demonstrated in several pediatric autoimmune diseases, including
autoimmune thyroid disease and Type-1 diabetes mellitus. This study was undertaken to
determine the prevalence of vitamin D deficiency in children with PANS, an autoimmune
disorder characterized by abrupt-onset neuropsychiatric symptoms. A retrospective chart review
of 122 pediatric PANS patients at a single treatment center was performed. Data collected
included 25-hydroxy vitamin D level, age, gender, and age of diagnosis. Vitamin D status was
categorized as deficient (0-<20 ng/ml) , insufficient (20-<30 ng/ml) and sufficient (30-100
ng/ml). Vitamin D status was evaluated by prespecified demographic data, including age of
PANS onset or diagnosis, gender, and deficiency range. 8% of patients were demonstrated to be
deficient, 24% were insufficient, and 68% were sufficient. 32% of all patients were either
deficient or insufficient. The odds ratio of vitamin D deficiency was 0.843505 [95% confidence
interval (CI): -2.91 to 4.59] in PANS patients, when compared to deficiency, insufficiency, and
sufficiency rates in the general US pediatric population. Vitamin D deficiency may be a risk
factor for PANS in children. Supplementation of vitamin D may play a role in management or
treatment of PANS.
Business Context:
Industry Description:
-

This internship is categorized under the pediatrics and pharmaceutical industries. A
pediatrician is a medical doctor that specializes in providing medical care to children.
They manage the physical, behavioral, and mental care for children from birth until age
18. They are also trained to diagnose and treat a broad range of childhood illnesses.
Concerning pharmacology, the pharmaceutical industry discovers, develops,
manufactures, and markets drugs or pharmaceuticals for use as medications to be
administered to patients, with the aim to cure them, vaccinate them, or alleviate the
symptoms. As a whole, the industry is led by the drug discovery process in which
professionals identify possible new drugs by examining their targets and corresponding
effects.

Company Description:
-

MASA Service Cooperation (SC) and MASA Food Allergy Center for Treatment is a
small healthcare company that was founded in 2013. It has principal locations in
Bloomington-Normal and Springfield, along with outreach offices that serve Central
Illinois. MASA specializes in health care services and drug development in clinical trials
within the medicinal industry. MASA offers services such as environmental and food
allergy testing, allergy action plans, asthma care, sinusitis treatment, immunology,
treatment for hives and contact dermatitis, etc. SWIA Clinical Research is the sister
company of MASA and has been in business for over 25 years while conducting nearly
1000 research trials. It focuses on full-time clinical research in all phases of drug and
medical device development.
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Department/Product Description:
-

As stated previously, this Internship is related to the pediatrics industry. The specific
autoimmune disease that I am collecting data on is Pediatric Autoimmune
Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) or
Pediatric Acute-onset Neuropsychiatric Syndrome (PANS). As a reference, PANDAS is
considered a subset of PANS. In general, PANS is often diagnosed with obsessivecompulsive disorder (OCD), eating disorder, and tic symptoms, but the sudden onset of
symptoms separates PANS from these other disorders. Specifically, PANDAS also
incorporates strep infections, such as strep throat or scarlet fever. PANDAS is diagnosed
when the aforementioned symptoms happen overnight or out of the blue. Both PANDAS
and PANS are immunological diseases associated with autoimmunity. For this internship,
I am reviewing the association between vitamin D deficiency and the occurrences of
PANDAS autoimmune disease in children.

Business Project Description:
Leading up to the internship, I researched peer-reviewed case studies and reports as background
literature to develop my familiarity with the topic I am researching. As a student intern, I
analyzed the status of vitamin D in children with PANS. In order to examine this phenomenon,
the research method that I used over the course of the internship was the MASA patient database
which included hundreds of patients that ranged from various backgrounds. At the beginning of
the internship, a typical I-Day consisted of me examining the MASA patient database to find
information including 25-hydroxy vitamin D levels, age, gender, race, and age of diagnosis. I
then populated a master spreadsheet with this data. After collecting and stratifying the data into
graphs, I began my analysis by calculating an odds ratio (OR) by cross-analyzing my data with a
similar case-control study. An example of a spreadsheet that I have worked on is shown below:
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Demographic data of 122 total patients was collected. Data from 91 patients is displayed in the
following graphs as either vitamin D 25-hydroxy levels for 31 patients could not be found or the
patients exceeded the age limit.
Table 1. Prevalence of vitamin D status by age and gender.
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This table showcases the vitamin D status by age and gender. 24.2% of my sample is categorized
as insufficient, 7.7% as deficient, and 68.1% as sufficient.
Figure 1. Age at PANS/PANDAS diagnosis vs. 25-hydroxy vitamin D.

This scatter plot showcases the age at which the patients were diagnosed with PANDAS in
relation to their current vitamin D level.
Figure 2. Vitamin D status of PANS/PANDAS pediatric population
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This graph showcases the number of patients and their respective vitamin D categories. 22
patients were determined to be insufficient, 7 were determined to be deficient, and 62 were
determined to be sufficient.
Table 2. Prevalence of vitamin D status in the PANS/PANDAS cohort compared with the
prevalence in a recently studied in a general US pediatric population (Kumar 2009 Pediatrics).

The Prevalence of vitamin D status is shown in the PANS/PANDAS cohort compared with the
prevalence in a recently studied in a general US pediatric population (Kumar 2009 Pediatrics).
The odds ratio comparing the two cohorts is noted, indicating a lower rate of vitamin D
deficiency or insufficiency in the PANS/PANDAS cohort studied, versus the general US
pediatric population.
Business Project Research:
As mentioned earlier, my business research was driven by the question to determine if there is an
association between vitamin D and children with PANS. There is much literature already
surrounding the relationship between vitamin D deficiency and the development of autoimmune
diseases. A comprehensive review of the implication of vitamin D and autoimmunity even
indicated that “increasing evidence demonstrates a strong association between vitamin D
signaling and many biological processes.”1A recent study has even discovered that vitamin D
supplementation with calcitriol could prevent both the initiation and progression of autoimmune
diseases such as experimental autoimmune encephalomyelitis, collagen-induced arthritis, and
experimental models of multiple sclerosis and rheumatoid arthritis.2 Most children consume less
than recommended amounts of vitamin D. In 2009, an observational study assessed the
prevalence and association of vitamin D deficiency in children with a nationally representative
sample of children aged 1 to 21 years. In this study, the researchers measured serum 25(OH)D
deficiency and insufficiency (25[OH]D <15 ng/mL and 15–29 ng/mL, respectively). In terms of
the general United States population, 9% (representing 7.6 million US children and adolescents)
of the sample were 25(OH)D deficient and 61% (representing 50.8 million US children and
adolescents) were 25(OH)D insufficient.3
Regarding the methodology used to explore my business research question, a chart review was
performed retrospectively from a single PANS/PANDAS treatment center. Data from patients
who presented to the specialty clinic for evaluation of PANS/PANDAS was collected.
1 In Annotated Bibliography
2 In Annotated Bibliography
3 In Annotated Bibliography
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Additional information collected included 25-hydroxy vitamin D levels, age, gender, race, and
age of diagnosis. Vitamin D status was stratified into three groups; deficiency (0 to < 20 ng/ml),
insufficiency (20 to < 30 ng/ml), and sufficiency (30-100 ng/ml). Patients were also stratified
into two age groups; child (< 12 years old) and adolescent (12-17 years old).
Overall, 24.2% of my sample are categorized as insufficient, 7.7% as deficient, and 68.1% as
sufficient. The odds ratio calculation was 0.843505 with a confidence interval from -2.91 to 4.59,
indicating a lower rate of vitamin D deficiency or insufficiency in the PANS/PANDAS cohort
studied, versus the general US pediatric population. Results indicate that our patient population
of children with PANS/PANDAS had a lower risk of vitamin D deficiency and insufficiency
status than those of the general US pediatric population regardless of their age or gender. The
results are inconsistent with the high prevalence of vitamin D deficiency/insufficiency status
reported in children with other autoimmune diseases.
Regarding previous Internship Business Reports, I have been able to increase sample size and
completely analyze the data that I collected since I am fortunate enough to have been able to
research this phenomenon for a long period of time.
Business Project Key Learnings & Recommendations:
1. Through this experience, I developed an appreciation of data collection and analysis. As
all of my findings depended on the source data I gathered from the MASA patient
database, it was imperative that I collected the data correctly, accurately, and
consistently. As the internship progressed, I had to create multiple spreadsheets with
hundreds of rows of data; thus, it was crucial that the data in each spreadsheet correlated
with data in past spreadsheets. In order to maintain consistency and accuracy, I learned
much about the various formulas that a researcher can use in google sheets. These
functions saved me so much time in collecting data. That said, I also learned about time
management. Data collection requires sufficient time even for small amounts of data. For
example, collected data for 30 rows of cells would usually require two hours to complete.
Due to this time requirement, I learned to allocate certain times during my day to simply
populate the spreadsheets.
2. Furthermore, I learned that there are multiple factors that can influence the outcome of a
scientific research study. Even though myself and my research mentors were surprised by
the negative correlation that we found, we understood that there are many variables that
contributed to this outcome. In our case, these variables included outside vitamin D
supplementation and sample ethnicity.
3. I also learned to collaborate with professionals in the field and hone my presentation
skills. Fortunately, my paper was published in abstract form in the February 2022 online
supplement of the Journal of Allergy and Clinical Immunology. Additionally, I was
chosen to present my research at the American Academy of Allergy Asthma and
Immunology annual conference to professionals in the pharmaceutical industry and
beyond in Phoenix, Arizona in February.
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4. I only have one small recommendation for my business mentor. Even though I am
unfamiliar with data collection and analysis in general, the collection overall would have
been easier in Excel rather than google sheets since Excel offers a multitude of more indepth functions. Despite this minute reservation, I am very satisfied with this internship
because it has given me experience in meeting deadlines, time management, and
collaborating with professionals as explained previously.
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Appendices:
An odds ratio (OR) was used to compare the relative odds of vitamin D deficiency in the general
United States population given the exposure to the PANDAS/PANS autoimmune diseases. An
OR was chosen instead of a risk ratio (RR) as this study reviews existing data and examines the
exposure to an intervention factor in relation to a predetermined outcome.
The formula used to calculate the OR is as follows where:
a = Number of exposed cases
b = Number if exposed non-cases
c = Number of unexposed cases
d = Number of unexposed non-cases
¿=

¿=

a /c ad
=
b/d bc

(n)exposed cases/(n)unexposed cases
(n)exposed non−cases/(n)unexposed non−cases
¿

(n)exposed cases×( n)unexposed non−cases
(n)exposed non−cases×(n)unexposed cases

Upper and lower confidence intervals were calculated to determine the range that the OR can fall
between. These intervals indicate the accuracy of the calculated OR.
The formula used to calculate the confidence intervals is as follows:

Upper 95% CI = e^[ln (OR)+1.96√ (1/a+1/b+1/c+1/d)]
Lower 95% CI = e^[ln (OR)−1.96√ (1/a+1/b+1/c+1/d)]
In the case of this study, the variables mean the following:
a = Patients with vitamin D deficiency/insufficiency and with PANDAS
b = Patients without vitamin D deficiency/insufficiency and with PANDAS
c = General population with vitamin D deficiency/insufficiency and without PANDAS
d = General population without vitamin D deficiency/insufficiency and without PANDAS

